Subscribe to Newsletter

Content by Mark Hillen:

Business & Profession Other

From Peer to Peer

| Mark Hillen

The Power List is gloriously subjective, because it's ophthalmologists who do the voting.

Business & Profession Health Economics and Policy

An Issue of Inequity

| Mark Hillen

Poorer people suffer poorer outcomes across all of medicine. Can eyecare buck the trend?

Subspecialties Other

Tears of Blood

| Mark Hillen

Are new ocular anticoagulants more or less likely than warfarin to cause intraocular bleeding?

Business & Profession Business and Innovation

OCT for all, and all for OCT

| Mark Hillen

Eye exams can detect more than ocular disease - is there a place in general practice for OCT?

Subspecialties Business and Innovation

Hindsight for Foresight

| Mark Hillen

Looking back at 2016's predictions of the future.

Subspecialties Refractive

Video: Multifocal patient selection

| Mark Hillen

Francesco Carones explains how the AcrySof IQ PanOptix IOL has affected his patient selection.

Business & Profession Professional Development

On Innovation…

| Mark Hillen

Advice on innovation from John Marshall - someone who's been there and done that.

Business & Profession Health Economics and Policy

The Mercy of The Markets

| Mark Hillen

If you're not a billionaire philanthropist, how do you raise money to make a difference?

Subspecialties Retina

PR – 10 Steps to Success

| Mark Hillen

Pneumatic retinopexy – an effective, inexpensive alternative to vitrectomy and scleral buckling?

Subspecialties Glaucoma

High On a Low Supply?

| Mark Hillen

OCT angiography discriminates between POAG, NTG and normal patients.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: